BIOCRYST PHARMACEUTICALS INC Insider Trading for January 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOCRYST PHARMACEUTICALS INC for January 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 5.45 | 5,000 | 27,250 | 7,000 | |
| Jan 30 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.85 | 5,000 | 49,250 | 128,426 | 133.4 K to 128.4 K (-3.75 %) |
| Jan 30 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 5.45 | 5,000 | 27,250 | 133,426 | 128.4 K to 133.4 K (+3.89 %) |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 2,000 | 6,440 | 79,427 | |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 4,000 | 12,880 | 81,427 | |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 6,000 | 19,320 | 85,427 | |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.91 | 2,000 | 19,820 | 0 | 2 K to 0 (-100.00 %) |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 2,000 | 6,440 | 2,000 | 0 to 2 K |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.88 | 4,000 | 39,520 | 0 | 4 K to 0 (-100.00 %) |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 4,000 | 12,880 | 4,000 | 0 to 4 K |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.60 | 6,000 | 57,600 | 0 | 6 K to 0 (-100.00 %) |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 6,000 | 19,320 | 6,000 | 0 to 6 K |
| Jan 23 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 2,000 | 6,440 | 91,427 | |
| Jan 23 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.40 | 2,000 | 18,800 | 0 | 2 K to 0 (-100.00 %) |
| Jan 23 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 2,000 | 6,440 | 2,000 | 0 to 2 K |
| Jan 18 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 3,046 | 9,808 | 93,427 | |
| Jan 18 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.27 | 3,046 | 28,236 | 0 | 3 K to 0 (-100.00 %) |
| Jan 18 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 3,046 | 9,808 | 3,046 | 0 to 3 K |
| Jan 16 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 954 | 3,072 | 96,473 | |
| Jan 16 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.20 | 954 | 8,777 | 0 | 954 to 0 (-100.00 %) |
| Jan 16 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 954 | 3,072 | 954 | 0 to 954 |
| Jan 08 2019 | BCRX | BIOCRYST PHARMACEU ... | ASELAGE STEVE | Director | Option Exercise | A | 8.62 | 25,000 | 215,500 | 25,000 | |
| Jan 03 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 8.07 | 771 | 6,222 | 108,100 | 108.9 K to 108.1 K (-0.71 %) |
| Jan 03 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 8.07 | 785 | 6,335 | 132,676 | 133.5 K to 132.7 K (-0.59 %) |
| Jan 03 2019 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 8.07 | 3,568 | 28,794 | 724,106 | 727.7 K to 724.1 K (-0.49 %) |